HOMEABOUT USNEWSCONTACT US
         
       
         
   

NeXeption, LLC is a biopharmaceutical management company that brings together product opportunities, management expertise and the necessary funding to reach compelling partnership milestones. The NeXeption management team has a proven track record in raising capital, operating development stage companies and forming strategic partnerships to advance products for the benefit of patients.
 

 

MARCH 17, 2015
Aclaris Therapeutics’ Lead Drug Candidate A-101 Achieves Statistically Significant Results in Third Phase 2 Clinical Trial for Seborrheic Keratosis, a Common Type of Benign Skin Tumor

JANUARY 27, 2015
Aclaris Therapeutics Announces Positive Results from Phase 2b Clinical Trial of A-101 for the Removal of Seborrheic Keratosis, a Common Type of Benign Skin Tumor

JANUARY 23, 2015
Alexar Awarded Michael J. Fox Foundation Grant for Research on a Novel Parkinson’s Disease Therapeutic